All patients referred for NMO antibody testing must have gone through either a Neurology or Ophthalmology review. Testing will be deferred on all specimens where it is unclear if a review has occurred. In this setting, direct discussion for approval of testing with a laboratory-based Clinical Immunologist must occur.